Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Wheat extends slide as worries mount over Omicron coronavirus

11/30/2021 | 03:24pm EST

* Stable U.S. crop rating, big Australia forecast also cool wheat

* Omicron worries revived by Moderna warning on vaccine response

* Corn, soybeans also slip on virus fears

CHICAGO, Nov 30 (Reuters) - Chicago wheat prices fell to a nearly three-week low on Tuesday, as concerns that the spread of the Omicron coronavirus variant could slow the global economy drove investors to reduce risk exposure.

The entire grains complex felt pressure early in the session, after Moderna Inc's chief executive cautioned that COVID-19 shots were unlikely to be as effective against the Omicron variant.

Corn followed wheat lower, while soybeans fell for a fifth straight session, as a sharp drop in the crude oil market and good weather for crop development in South America added to the pressure on prices.

"The overwhelming fundamental in the market right now is fear over Omicron and what it could do to demand," said Jack Scoville, market analyst at The Price Futures Group, who noted that much of the sell-off was caused by funds seeking cover.

"Hopefully, we'll be seeing some better (export) demand with these weaker prices," Scoville said. If that happens, "we should be getting to the end of this panic selling and things should stabilize."

The most-active wheat contract on the Chicago Board Of Trade (CBOT) settled down 35 cents at $7.87-1/5 a bushel. Earlier in the session, the contract fell to $7.82-1/2, its lowest since Nov. 10.

CBOT soybeans settled down 24-1/4 cents to $12.17-1/4 a bushel, while corn settled 14-3/4 cents lower to $5.67-1/2 a bushel.

Wheat markets rallied to nine-year highs this month in Chicago and record peaks on Euronext as the possibility of more Russian export restrictions and the risk of rain damage to Australia's crop fanned fears of tight milling wheat supplies.

Egypt, the world's biggest wheat importer, also made its largest single wheat purchase in years on Monday after under-buying this season, given a surge in prices. But it is not known if Egypt will continue its buying spree or was just taking advantage of a dip in prices.

Global supply worries were eased by signs of a stabilizing U.S. crop, and after Australia's chief commodity forecaster, ABARES, revised its official estimate for the 2021/22 crop to a record 34.4 million tonnes. (Reporting by P.J. Huffstutter; Additional reporting by Gus Trompiz in Paris and Naveen Thukral in Singapore; Editing by Kirsten Donovan, Barbara Lewis and Peter Cooney)


ę Reuters 2021
All news about MODERNA, INC.
01/19Prior COVID infection more protective than vaccination during Delta surge, U.S. study f..
RE
01/19Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
01/18US Stocks Slump as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on Financials
MT
01/18US Stocks Start Week Lower as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on ..
MT
01/18Morgan Stanley Adjusts Moderna Price Target to $315 From $313, Maintains Equal Weight R..
MT
01/18Equities Slump Midday After Treasury Yields Touch Two-Year High, Goldman's Earnings Mis..
MT
01/18MIDDAY REPORT : US Stocks Slump After Treasury Yields Touch Two-Year High; Goldman's Earni..
MT
01/18EU regulator finds mRNA COVID-19 shots safe during pregnancy
RE
01/18European Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
01/18EU regulator says mRNA COVID-19 shots do not complicate pregnancies
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 520 M - -
Net income 2021 11 079 M - -
Net cash 2021 9 774 M - -
P/E ratio 2021 6,59x
Yield 2021 -
Capitalization 70 577 M 70 577 M -
EV / Sales 2021 3,47x
EV / Sales 2022 2,36x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 174,07 $
Average target price 273,19 $
Spread / Average Target 56,9%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-31.46%75 661
LONZA GROUP AG-15.05%52 427
IQVIA HOLDINGS INC.-14.11%46 293
SEAGEN INC.-15.72%23 824
ICON PUBLIC LIMITED COMPANY-17.86%20 707
CELLTRION, INC.-15.66%18 630